Dr. Martin explains the role of biological age, NAD levels, and advanced diagnostics in guiding long-term health strategies.
More than 250 million people worldwide live with chronic hepatitis B (HBV), yet there is still no accessible animal model for studying the disease or testing novel therapies. Researchers have now ...
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...
Teemu Miettinen discusses his innovative method for measuring intracellular water, revealing its critical role in cell ...
Even when bacteria appear susceptible in routine tests, tolerance can let them survive therapy long enough to drive ...
2don MSN
New clues to hepatitis B species restriction could help build a novel model for studying infection
Some 254 million people live with a chronic hepatitis B (HBV) infection that is often asymptomatic for decades, only to ...
A new nanomedicine strategy enhances irinotecan delivery in pancreatic tumors, reduces resistance, and boosts antitumor ...
Bismuth-doped gallium nanoparticles transform into cell-puncturing spikes under freezing, killing drug-resistant lung, ...
Korea showcases cancer advances at AACR with targeted and RNA therapies, CDMO push Korean biotechs spotlight early wins in ...
Quantumtronix Inc., a pioneer in integrated cellular engineering, today announced that the inaugural production run of Carno Lux, its flagship cellular-targeting supplement, sold out within 60 days of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results